Addus HomeCare Co. (NASDAQ:ADUS - Free Report) - Investment analysts at William Blair issued their Q1 2026 earnings estimates for Addus HomeCare in a report released on Monday, June 9th. William Blair analyst J. Haase expects that the company will post earnings per share of $1.35 for the quarter. The consensus estimate for Addus HomeCare's current full-year earnings is $4.59 per share. William Blair also issued estimates for Addus HomeCare's Q2 2026 earnings at $1.46 EPS, Q3 2026 earnings at $1.53 EPS and Q4 2026 earnings at $1.80 EPS.
A number of other research firms have also commented on ADUS. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Stephens reaffirmed an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. Macquarie reiterated an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a report on Tuesday. Finally, Wall Street Zen downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $142.57.
Read Our Latest Report on ADUS
Addus HomeCare Price Performance
Shares of ADUS stock traded up $0.20 during trading on Wednesday, reaching $112.89. The company had a trading volume of 31,613 shares, compared to its average volume of 169,474. Addus HomeCare has a one year low of $88.96 and a one year high of $136.72. The firm's 50 day simple moving average is $106.81 and its two-hundred day simple moving average is $112.38. The company has a market capitalization of $2.08 billion, a PE ratio of 25.83, a PEG ratio of 1.41 and a beta of 0.81.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. During the same period in the previous year, the company posted $1.21 EPS. Addus HomeCare's revenue was up 20.3% on a year-over-year basis.
Hedge Funds Weigh In On Addus HomeCare
Institutional investors have recently modified their holdings of the stock. Empowered Funds LLC increased its position in shares of Addus HomeCare by 31.3% in the 4th quarter. Empowered Funds LLC now owns 18,227 shares of the company's stock valued at $2,285,000 after buying an additional 4,340 shares in the last quarter. Equitable Trust Co. raised its position in shares of Addus HomeCare by 47.1% during the fourth quarter. Equitable Trust Co. now owns 7,096 shares of the company's stock worth $889,000 after purchasing an additional 2,271 shares during the period. Vontobel Holding Ltd. raised its position in shares of Addus HomeCare by 22.9% during the fourth quarter. Vontobel Holding Ltd. now owns 3,132 shares of the company's stock worth $393,000 after purchasing an additional 583 shares during the period. Vista Finance LLC bought a new position in shares of Addus HomeCare during the 4th quarter valued at about $351,000. Finally, State of New Jersey Common Pension Fund D grew its position in shares of Addus HomeCare by 17.1% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 17,464 shares of the company's stock valued at $2,189,000 after purchasing an additional 2,553 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the sale, the executive vice president now directly owns 7,796 shares in the company, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 4.60% of the stock is currently owned by company insiders.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.